Table:
begin	end	state
1	26	cytoplasmic
27	47	transmembrane
48	53	non-cytoplasmic
54	73	transmembrane
74	106	cytoplasmic
107	129	transmembrane
130	134	non-cytoplasmic
135	153	transmembrane
154	163	cytoplasmic
164	186	transmembrane
187	206	non-cytoplasmic
207	229	transmembrane
230	249	cytoplasmic
250	270	transmembrane
271	290	non-cytoplasmic
291	313	transmembrane
314	344	cytoplasmic
345	362	transmembrane
363	367	non-cytoplasmic
368	389	transmembrane
390	409	cytoplasmic
410	432	transmembrane
433	437	non-cytoplasmic
438	457	transmembrane
458	473	cytoplasmic

Input:
>AO356_17670 AO356_17670 D-alanine/D-serine/glycine permease
MPVGNHLPHGETAQGGPLKRELGERHIRLMALGACIGVGLFLGSAKAIEMAGPAIMLSYI
IGGLAILVIMRALGEMAVHNPVAGSFSRYAQDYLGPLAGFLTGWNYWFLWLVTCVAEITA
VAVYMGIWFPDVPRWIWALAALVSMGSINLIAVKAFGEFEFWFALIKIVTIIAMVIGGVG
IIAFGFGNDGVALGISNLWAHGGFMPNGVSGVLMSLQMVMFAYLGVEMIGLTAGEAKNPQ
KTIPNAIGSVFWRILLFYVGALFVILSIYPWNEIGTQGSPFVMTFERLGIKTAAGIINFV
VITAALSSCNGGIFSTGRMLYSLAQNGQAPAGFAKTSTNGVPRRALLLSIAALLLGVLLN
YLVPEKVFVWVTSIATFGAIWTWVMILLAQLKFRKSLSASERAALKYRMWLYPVSSYLAL
AFLVLVVGLMAYFPDTRVALYVGPAFLVLLTVLFYTFKLQPTGDVQRAVRSAS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server